| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-8 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-9 ERVK-10 ERVK-24 | 1.11e-16 | 37 | 76 | 10 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-8 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-9 ERVK-10 ERVK-24 | 1.50e-16 | 38 | 76 | 10 | GO:0070001 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.17e-10 | 11 | 76 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 USP14 THOP1 ERVK-8 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-9 ERVK-10 MMP8 ERVK-24 USP48 | 7.62e-10 | 430 | 76 | 14 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.36e-09 | 14 | 76 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.36e-08 | 21 | 76 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 USP31 USP14 THOP1 ERVK-8 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-9 ERVK-10 MMP8 ERVK-24 USP48 | 2.04e-08 | 654 | 76 | 15 | GO:0008233 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ASAH2 ERVK-8 ERVK-5 ERVK-19 CHD4 ERVK-7 ERVK-21 ERVK-9 ERVK-10 MMP8 ERVK-24 ERVK-11 CBLB RBM20 ZFP37 | 1.89e-07 | 891 | 76 | 16 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.77e-07 | 37 | 76 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 3.18e-07 | 38 | 76 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 8.48e-07 | 46 | 76 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | structural molecule activity | MYBPH ERVK-6 POSTN IGF1R NPAP1 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-9 ERVK-10 ERVK-24 | 1.09e-06 | 891 | 76 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 ASAH2 ERVK-8 ERVK-5 ERVK-19 CHD4 ERVK-7 ERVK-21 ERVK-9 ERVK-10 MMP8 ERVK-24 ERVK-11 CBLB RBM20 ZFP37 | 8.24e-06 | 1189 | 76 | 16 | GO:0046914 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.26e-05 | 79 | 76 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.32e-05 | 136 | 76 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 5.77e-05 | 20 | 76 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.25e-05 | 262 | 76 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.71e-04 | 136 | 76 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.50e-04 | 231 | 76 | 6 | GO:0004518 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 2.86e-04 | 152 | 76 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 3.11e-04 | 85 | 76 | 4 | GO:0008135 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 8.82e-04 | 112 | 76 | 4 | GO:0090079 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 1.45e-03 | 15 | 76 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 MET IGF1R PIK3CA CAMK2A ERVK-8 ERVK-7 ERVK-10 ERVK-11 AURKB | 2.86e-03 | 938 | 76 | 10 | GO:0016772 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 3.10e-03 | 645 | 76 | 8 | GO:0140640 | |
| GeneOntologyBiologicalProcess | DNA integration | 9.11e-10 | 13 | 79 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 7.77e-07 | 83 | 79 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.09e-06 | 48 | 79 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 ERVK-8 ERVK-5 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 EEF1A1 | 1.08e-05 | 464 | 79 | 10 | GO:0016032 |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.87e-05 | 85 | 79 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.87e-05 | 85 | 79 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.34e-05 | 89 | 79 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 6.26e-05 | 178 | 79 | 6 | GO:0006261 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 1.90e-04 | 218 | 79 | 6 | GO:0071897 | |
| GeneOntologyBiologicalProcess | DNA replication | 1.93e-04 | 312 | 79 | 7 | GO:0006260 | |
| Domain | G_TR_1 | 8.53e-04 | 13 | 63 | 2 | PS00301 | |
| Domain | USP_CS | 1.44e-03 | 66 | 63 | 3 | IPR018200 | |
| Domain | EFTu-like_2 | 1.65e-03 | 18 | 63 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 1.65e-03 | 18 | 63 | 2 | PF03144 | |
| Domain | G_TR_2 | 1.65e-03 | 18 | 63 | 2 | PS51722 | |
| Domain | USP_1 | 1.70e-03 | 70 | 63 | 3 | PS00972 | |
| Domain | UCH | 1.78e-03 | 71 | 63 | 3 | PF00443 | |
| Domain | USP_2 | 1.78e-03 | 71 | 63 | 3 | PS00973 | |
| Domain | TF_GTP-bd_dom | 1.85e-03 | 19 | 63 | 2 | IPR000795 | |
| Domain | USP_3 | 1.85e-03 | 72 | 63 | 3 | PS50235 | |
| Domain | USP_dom | 1.85e-03 | 72 | 63 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.85e-03 | 72 | 63 | 3 | IPR001394 | |
| Domain | zf-CCHC | 2.71e-03 | 23 | 63 | 2 | PF00098 | |
| Domain | Transl_B-barrel | 3.72e-03 | 27 | 63 | 2 | IPR009000 | |
| Domain | ZF_CCHC | 6.20e-03 | 35 | 63 | 2 | PS50158 | |
| Domain | UBIQUITIN_1 | 6.91e-03 | 37 | 63 | 2 | PS00299 | |
| Pathway | WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS | 1.49e-05 | 14 | 50 | 3 | M45553 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 7.15e-05 | 63 | 50 | 4 | M27862 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.03e-04 | 26 | 50 | 3 | MM1371 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 1.83e-04 | 6 | 50 | 2 | M27741 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 1.83e-04 | 6 | 50 | 2 | MM15489 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-9 ERVK-10 ERVK-24 ERVK-11 | 3.24e-18 | 94 | 79 | 12 | 21542922 |
| Pubmed | 7.41e-15 | 18 | 79 | 7 | 18664271 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.32e-14 | 5 | 79 | 5 | 12629516 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.47e-11 | 4 | 79 | 4 | 10469592 | |
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 7983737 | ||
| Pubmed | 4.16e-11 | 12 | 79 | 5 | 14557543 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 10516026 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 9971820 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 25090459 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.12e-07 | 5 | 79 | 3 | 11401426 | |
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 15063128 | ||
| Pubmed | 1.34e-06 | 10 | 79 | 3 | 12970426 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 25483727 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16891453 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21729677 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28418902 | ||
| Pubmed | Igf1r as a therapeutic target in a mouse model of basal-like breast cancer. | 5.09e-06 | 2 | 79 | 2 | 19174523 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 9060628 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 14597618 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23389689 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 5.09e-06 | 2 | 79 | 2 | 9460924 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26832731 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23873272 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 25916750 | ||
| Pubmed | Circadian Gene Circuitry Predicts Hyperactive Behavior in a Mood Disorder Mouse Model. | 5.09e-06 | 2 | 79 | 2 | 27028761 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26543351 | ||
| Pubmed | USP48 Governs Cell Cycle Progression by Regulating the Protein Level of Aurora B. | 5.09e-06 | 2 | 79 | 2 | 34445214 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 5.09e-06 | 2 | 79 | 2 | 11672541 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28619752 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32033461 | ||
| Pubmed | Aurora B regulates formin mDia3 in achieving metaphase chromosome alignment. | 5.09e-06 | 2 | 79 | 2 | 21397845 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28662510 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 30675529 | ||
| Pubmed | 1.06e-05 | 19 | 79 | 3 | 31959764 | ||
| Pubmed | Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma. | 1.53e-05 | 3 | 79 | 2 | 22020193 | |
| Pubmed | Ligand-independent activation of MET through IGF-1/IGF-1R signaling. | 1.53e-05 | 3 | 79 | 2 | 23526299 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 32978479 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 22343486 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 26033401 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 22067224 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 20112500 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 29137928 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 9415396 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 28258248 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 29855336 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 28742836 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 24973425 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 16214042 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 26334097 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 20061986 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 18938767 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 21538027 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 4.01e-05 | 558 | 79 | 8 | 35063084 | |
| Pubmed | 4.96e-05 | 421 | 79 | 7 | 36976175 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 28292957 | ||
| Pubmed | Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. | 5.07e-05 | 5 | 79 | 2 | 11526404 | |
| Pubmed | Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition. | 5.07e-05 | 5 | 79 | 2 | 27048245 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 17682062 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 19812598 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 26173098 | ||
| Pubmed | Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks. | 7.60e-05 | 6 | 79 | 2 | 23861540 | |
| Pubmed | Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. | 1.06e-04 | 7 | 79 | 2 | 12904469 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 2482828 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 27474268 | ||
| Pubmed | 1.33e-04 | 493 | 79 | 7 | 15368895 | ||
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 23260144 | ||
| Pubmed | ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation. | 1.41e-04 | 8 | 79 | 2 | 30563862 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.47e-04 | 861 | 79 | 9 | 36931259 | |
| Pubmed | Thioredoxin Txnl1/TRP32 is a redox-active cofactor of the 26 S proteasome. | 1.82e-04 | 9 | 79 | 2 | 19349277 | |
| Pubmed | 1.82e-04 | 9 | 79 | 2 | 24285539 | ||
| Pubmed | Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells. | 2.27e-04 | 10 | 79 | 2 | 24051437 | |
| Pubmed | A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. | 2.76e-04 | 11 | 79 | 2 | 8247543 | |
| Pubmed | Lineage-specific responses to reduced embryonic Pax3 expression levels. | 2.76e-04 | 11 | 79 | 2 | 18243171 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 3.00e-04 | 256 | 79 | 5 | 24189400 | |
| Pubmed | 3.31e-04 | 12 | 79 | 2 | 12435421 | ||
| Pubmed | 3.58e-04 | 266 | 79 | 5 | 19380743 | ||
| Pubmed | 3.60e-04 | 147 | 79 | 4 | 29576527 | ||
| Pubmed | 3.69e-04 | 61 | 79 | 3 | 27166947 | ||
| Pubmed | Interaction network of human aminoacyl-tRNA synthetases and subunits of elongation factor 1 complex. | 3.91e-04 | 13 | 79 | 2 | 11829477 | |
| Pubmed | 3.98e-04 | 151 | 79 | 4 | 17043677 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP14 EFL1 THOP1 PPP5C AGL EIF2B3 HARS1 ATE1 USP48 EEF1A1 AHNAK2 | 4.39e-04 | 1455 | 79 | 11 | 22863883 |
| Pubmed | Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. | 4.40e-04 | 155 | 79 | 4 | 22673621 | |
| Pubmed | A molecular dissection of the repression circuitry of Ikaros. | 4.55e-04 | 14 | 79 | 2 | 12015313 | |
| Pubmed | 4.55e-04 | 14 | 79 | 2 | 21875947 | ||
| Pubmed | 4.82e-04 | 284 | 79 | 5 | 15057824 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 4.96e-04 | 807 | 79 | 8 | 30575818 | |
| Pubmed | Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation. | 5.08e-04 | 68 | 79 | 3 | 25754235 | |
| Pubmed | 5.25e-04 | 15 | 79 | 2 | 8812466 | ||
| Pubmed | TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. | 5.25e-04 | 15 | 79 | 2 | 19321449 | |
| Pubmed | 5.31e-04 | 69 | 79 | 3 | 32238831 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 5.77e-04 | 71 | 79 | 3 | 28319113 | |
| Pubmed | A strategy for modulation of enzymes in the ubiquitin system. | 6.78e-04 | 17 | 79 | 2 | 23287719 | |
| Pubmed | Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases. | 6.78e-04 | 17 | 79 | 2 | 27398409 | |
| Pubmed | LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. | 7.61e-04 | 18 | 79 | 2 | 19497860 | |
| Pubmed | 8.17e-04 | 80 | 79 | 3 | 28205554 | ||
| Pubmed | 8.47e-04 | 81 | 79 | 3 | 12838346 | ||
| Pubmed | 9.43e-04 | 20 | 79 | 2 | 22267199 | ||
| Pubmed | CECR2 is involved in spermatogenesis and forms a complex with SNF2H in the testis. | 1.04e-03 | 21 | 79 | 2 | 22154806 | |
| Pubmed | 1.04e-03 | 87 | 79 | 3 | 24169447 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.08e-03 | 910 | 79 | 8 | 36736316 | |
| GeneFamily | Ubiquitin specific peptidases | 2.56e-04 | 56 | 40 | 3 | 366 | |
| GeneFamily | CTAGE family | 4.92e-04 | 15 | 40 | 2 | 907 | |
| Coexpression | GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN | 9.28e-06 | 193 | 66 | 6 | M7575 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.92e-07 | 195 | 67 | 6 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.94e-06 | 157 | 67 | 5 | abfd05ed993b80822739f47a735f154092a23632 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.45e-06 | 188 | 67 | 5 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 189 | 67 | 5 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 189 | 67 | 5 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.95e-06 | 190 | 67 | 5 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 9.95e-06 | 190 | 67 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 194 | 67 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Transverse-T_cell-cycling_gd_T|Transverse / Region, Cell class and subclass | 1.21e-05 | 198 | 67 | 5 | 5131b0b7d6c4dd8872cef9f2e233f59f751b4690 | |
| ToppCell | Transverse-(1)_T_cell-(18)_cycling_gd_T|Transverse / shred on region, Cell_type, and subtype | 1.21e-05 | 198 | 67 | 5 | 396dddf7ebad41c3a91329b6a280623c0dfdcd2f | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-05 | 132 | 67 | 4 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-05 | 132 | 67 | 4 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-05 | 132 | 67 | 4 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Slco2a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.84e-05 | 133 | 67 | 4 | 9d7a08170d38ae9b2ff10a0fa505aeb3aae2824d | |
| Disease | gastrinoma (is_marker_for) | 1.34e-05 | 3 | 63 | 2 | DOID:5577 (is_marker_for) | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 1.34e-05 | 3 | 63 | 2 | DOID:0080463 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.64e-05 | 80 | 63 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | HEPATOCELLULAR CARCINOMA | 1.60e-04 | 9 | 63 | 2 | 114550 | |
| Disease | Hepatocellular carcinoma | 1.60e-04 | 9 | 63 | 2 | cv:C2239176 | |
| Disease | melanoma | 1.90e-04 | 248 | 63 | 5 | C0025202 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 2.00e-04 | 10 | 63 | 2 | DOID:7693 (is_marker_for) | |
| Disease | Paroxysmal atrial fibrillation | 3.51e-04 | 156 | 63 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.51e-04 | 156 | 63 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.51e-04 | 156 | 63 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 3.87e-04 | 160 | 63 | 4 | C0004238 | |
| Disease | Benign neoplasm of stomach | 5.98e-04 | 17 | 63 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.98e-04 | 17 | 63 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 5.98e-04 | 17 | 63 | 2 | C0154060 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 6.15e-04 | 181 | 63 | 4 | DOID:684 (is_implicated_in) | |
| Disease | periodontitis (biomarker_via_orthology) | 9.18e-04 | 21 | 63 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | Stomach Carcinoma | 9.18e-04 | 21 | 63 | 2 | C0699791 | |
| Disease | cerebrospinal fluid biomarker measurement | 1.15e-03 | 96 | 63 | 3 | EFO_0006794 | |
| Disease | atrial fibrillation | 1.18e-03 | 371 | 63 | 5 | EFO_0000275 | |
| Disease | Neoplasm of the genitourinary tract | 1.20e-03 | 24 | 63 | 2 | cv:C0042065 | |
| Disease | breast cancer (implicated_via_orthology) | 1.30e-03 | 25 | 63 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.41e-03 | 26 | 63 | 2 | DOID:234 (is_implicated_in) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 1.57e-03 | 107 | 63 | 3 | DOID:6000 (biomarker_via_orthology) | |
| Disease | chronic kidney disease | 1.62e-03 | 235 | 63 | 4 | EFO_0003884 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 1.64e-03 | 28 | 63 | 2 | DOID:7998 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAKEDPVCAPESMGS | 271 | Q9NUB1 | |
| PVCAPESMGSEDMLF | 276 | Q9NUB1 | |
| TDDRCPAKPEEEGMM | 26 | O42043 | |
| CPAKPEEEGMMINIS | 141 | O71037 | |
| CPAKPEEEGMMINIS | 141 | Q902F8 | |
| CPAKPEEEGMMINIS | 141 | Q9UKH3 | |
| VEQDCKMMFPPPGQS | 601 | Q86UF2 | |
| VEQDCKMMFPPPGQS | 601 | A4D2H0 | |
| MNGDCVMDKPLDLSD | 481 | Q99708 | |
| AGCTLIPDKKPMAAM | 736 | Q76N32 | |
| PMCEEPLMGVCFVLE | 881 | Q7Z2Z2 | |
| KCFAFMEMDEIKPGP | 256 | Q96BJ3 | |
| PVPFKDIMKDECSML | 666 | Q9C0I3 | |
| DCSAAPLEMMENFPK | 101 | Q9NSV4 | |
| MSPSLFLPAMKEGCN | 386 | Q86XH1 | |
| PPEANGVIMMLKSCD | 81 | Q86Y37 | |
| ETLDMMKKPRCGVPD | 81 | P22894 | |
| CPSDMDVEMPGLNLD | 991 | Q5T481 | |
| KSLGTPEDGMAVCMF | 121 | Q9NTX5 | |
| PSMCIAKGPGQDMFD | 381 | Q9NR71 | |
| CSIIDPFGMPMLDLD | 436 | Q13191 | |
| LCPGTMEEKPMCEKT | 181 | P08069 | |
| MEGGLLDKPDNCPDM | 1226 | P08069 | |
| LDKPDNCPDMLFELM | 1231 | P08069 | |
| EMMLLPDCCYSDDGP | 91 | Q32MH5 | |
| AMRSCDFGDGMKEVP | 426 | Q9ULS6 | |
| SDPMLEGCRMYKPLA | 476 | A0A1B0GTW7 | |
| LSADDAFMMAPKPGL | 231 | Q8TB73 | |
| MESGPKMLAPVCLVE | 1 | Q6ZN66 | |
| LSGMPECKFGMNDKI | 206 | Q96CW1 | |
| CPAKPEEEGMMINIS | 901 | P63135 | |
| IGMPVCEFDMVKDPE | 121 | P42336 | |
| DMSKPPCYEEAVLMA | 146 | Q8TB68 | |
| LQMPVLGMTPADDFC | 76 | O14531 | |
| MKPDIVCIPDDADMG | 71 | Q9NR50 | |
| RVPPFSEEVFMECMG | 4496 | Q4G0P3 | |
| TDDRCPAKPEEEGMM | 26 | P61566 | |
| CPAKPEEEGMMINIS | 141 | P61570 | |
| CPAKPEEEGMMINIS | 141 | Q69384 | |
| IDDRCPAKPEEEGMM | 26 | P61567 | |
| IVDMVPGKPMCVESF | 401 | P68104 | |
| GPLPMEAIEKMASLC | 66 | Q6P1N0 | |
| PFDQDAVNMLCMPKG | 71 | Q6ZUT9 | |
| IDDRCPAKPEEEGMM | 136 | P61565 | |
| TDDRCPAKPEEEGMM | 26 | Q9HDB8 | |
| GPTMTEKAEMVCAPS | 11 | P12980 | |
| MPECKNPFKLMIGSS | 161 | Q9P267 | |
| VPKGSCEDEPMDSTM | 106 | O95260 | |
| IVDMVPGKPMCVESF | 401 | Q5VTE0 | |
| CPAKPEEEGMMINIS | 141 | Q902F9 | |
| VDPVSLGKMDPMCSG | 416 | Q7Z2K8 | |
| AYHMVCLDPDMEKAP | 391 | Q14839 | |
| NFDPMIPDAECLKIM | 181 | P12081 | |
| PDSAEPMDRSAMCAF | 351 | P08581 | |
| MAMAEGERTECAEPP | 1 | P53041 | |
| EGPEPMCLFMAPFET | 196 | O15218 | |
| GSGPPRQFMDCMADK | 1301 | Q6ZUB1 | |
| MMEKNTSEGPACSPE | 1 | Q13203 | |
| KMCDPGMTAFEPEAL | 371 | Q9UQM7 | |
| DTKAPMMPLSCFLGN | 181 | Q9BSU1 | |
| LMSGKRMPDEKPFCI | 296 | Q9NZP6 | |
| ACSEPSMQMPKVGFA | 4751 | Q8IVF2 | |
| EFKECMECLEKPMAP | 901 | Q96JN2 | |
| EMGKLALEPGENFCM | 206 | Q86X52 | |
| MEPKASCPAAAPLME | 1 | Q96CD2 | |
| KTMCGTLDYLPPEMI | 231 | Q96GD4 | |
| MDDPRYGMCPLKGAS | 1 | Q8IYN0 | |
| PLDCMIKMVAQEGPT | 256 | P55916 | |
| SPIEGMVMKEGDCNF | 91 | Q5VYX0 | |
| CVAPGKRFMPMDNLS | 1111 | Q8NDV3 | |
| AAGDSPALMTDPCMS | 41 | Q9P246 | |
| PDMAANFCPDHKAPM | 2351 | Q15413 | |
| ASMFPENGVPDDMKE | 241 | Q92800 | |
| CPAKPEEEGMMINIS | 901 | P10266 | |
| CPAKPEEEGMMINIS | 901 | Q9UQG0 | |
| MPQKSDNGEVECSMP | 821 | Q5JVG2 | |
| DSGMPKDRFSAEMPD | 76 | A0A1B0GX78 | |
| ETDMMPEGPSFPVCS | 261 | Q70CQ4 | |
| MEGMKGCPAVLPIDH | 86 | Q15063 | |
| MMGSADALPEEPSAK | 71 | P54578 | |
| LDIPSCMDEECMLPS | 2016 | P31629 | |
| MKPPAACAGDMADAA | 1 | P52888 | |
| DVMQVCMPEEGFKGT | 1016 | Q86UV5 | |
| MGCQAPKPDMISKLE | 71 | Q9Y6Q3 | |
| EPAMRKDDVCPGMKC | 116 | Q6F5E7 | |
| GPVGMPKEATCDHFM | 101 | Q8TEU8 | |
| PLGMKTLDPDDMVYC | 1411 | P35573 |